# A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

> clinical trial · VERIFIED · 2026-07-29

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Secondary Progressive Multiple Sclerosis (SPMS)

- Company: Novartis Pharmaceuticals
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07225504

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.